Supplements for article: The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: results from a placebo-controlled, phase 3 study

Name: Supplements for article: The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: results from a placebo-controlled, phase 3 study
Creator: Amy Paller
Published: 2024-09-20T18:27:46.043Z
Keywords: Atopic Dermatitis, Quality of Life, Quality of Sleep, Patient-Reported Outcome

Paller, Amy; Silverberg, Jonathan; Simpson, Eric; Cork, Michael; Arkwright, Peter; Chen, Zhen; Bansal, Ashish; Prescilla, Randy; Wang, Zhixiao; Marco, Ainara

doi:10.17632/9xvwbfz598.1

Supplements for article: The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: results from a placebo-controlled, phase 3 study

Published: 20 September 2024| Version 1 | DOI: 10.17632/9xvwbfz598.1

Contributors:

Amy Paller, Jonathan Silverberg, Eric Simpson, Michael Cork, Peter Arkwright, Zhen Chen, Ashish Bansal, Randy Prescilla, Zhixiao Wang, Ainara Marco

Description

Supplements for article with title: The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: results from a placebo-controlled, phase 3 study Journal: Journal of the American Academy of Dermatology

Supplements for article: The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: results from a placebo-controlled, phase 3 study

Description

Files

Categories

Funding

Licence